FDA Inspection 908381 — TriRx Huntsville Pharmaceutical Services, LLC
The FDA completed an inspection of TriRx Huntsville Pharmaceutical Services, LLC on December 19, 2014 in Huntsville, AL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 19, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Huntsville, AL (United States)